BioRestorative Therapies’ Stockholders Approve Institutional Investor Agreement and Exchange Agreements

    NEXT STORY
    Generex Announces Webcast
    PREV STORY
    PAVmed Reports Second Quarter 2019 Financial Results and Provides Business Update
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Intra-Cellular Therapies Announces Presentations on Lumateperone at Two Upcoming Medical Conferences

    NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Kura Oncology to Present at the Leerink Partners 7th Annual Global Healthcare Conference

    SAN DIEGO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    TESARO Announces Fourth-Quarter and Full-Year 2017 Operating Results

    ZEJULA is the #1 PARP inhibitor for women with ovarian cancer in the U.S.2017 ...

    author_avatar
    NASDAQ Market News